borderline significantp=0.05
In addition, there was a borderline significant reduction in disease recurrence rate (OR: 0.74, 95% CI: 0.55-1.0, p=0.05) [ 32 ].
In addition, there was a borderline significant reduction in disease recurrence rate (OR: 0.74, 95% CI: 0.55-1.0, p=0.05) [ 32 ].
In 98 evaluable patients, assessed at a median follow-up of 7.1 years, early hormone therapy showed highly significant advantages, as shown by significantly increased cancer-specific, progression-free, and overall survival rates.